Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $12.5800 (-5.06%) ($12.5800 - $12.5800) on Sat. Sep. 24, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.49% (three month average) | RSI | 41 | Latest Price | $12.5800(-5.06%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -2.6% a day on average for past five trading days. | Weekly Trend | EDIT declines -5.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting EDIT price | EDIT will decline at least -2.745% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.745% (StdDev 5.49%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $2.51(-80.05%) | Resistance Level | $14.81 | 5 Day Moving Average | $13.78(-8.71%) | 10 Day Moving Average | $14.44(-12.88%) | 20 Day Moving Average | $14.81(-15.06%) | To recent high | -34.9% | To recent low | 7.1% | Market Cap | $N/A | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |